🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.69
+0.28 (1.06%)
Nov 18, 2026, 4:00 PM EST - Market closed

Stoke Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
107.2784.22127.98191.44113.56144.9
Short-Term Investments
211.92200.4588.929.95116.0474.92
Cash & Short-Term Investments
319.19284.67216.9201.39229.6219.81
Cash Growth
28.54%31.25%7.70%-12.28%4.45%-23.49%
Accounts Receivable
8.545.941.67---
Other Receivables
1.531.970.70.060.590.13
Receivables
10.087.912.370.060.590.13
Prepaid Expenses
17.68.7411.1211.3210.936.94
Restricted Cash
-0.490.08---
Other Current Assets
7.563.92.32.562.962.33
Total Current Assets
354.42305.7232.76215.34244.07229.22
Property, Plant & Equipment
9.456.258.2512.4311.439.08
Long-Term Investments
39.6106.2629.82---
Other Long-Term Assets
3.230.230.720.570.570.57
Total Assets
406.69418.43271.56228.34256.07238.87

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.034.942.51.70.772.39
Accrued Expenses
35.5936.9715.4910.912.8812.71
Current Portion of Leases
1.243.012.322.062.361.51
Current Unearned Revenue
6.3611.918.9915.3114.88-
Other Current Liabilities
1.751.060.750.860.510.54
Total Current Liabilities
48.9857.8840.0630.8231.3917.14
Long-Term Leases
0.681.142.454.772.723.53
Long-Term Unearned Revenue
4.456.96-33.0736.86-
Other Long-Term Liabilities
0-0.030.110.250.42
Total Liabilities
54.165.9842.5368.7871.2221.09

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
1,037849.62720561.43483.17414.02
Retained Earnings
-682.98-497.72-490.83-401.85-297.15-196.08
Comprehensive Income & Other
-1.050.54-0.15-0.02-1.18-0.17
Total Common Equity
352.59352.46229.02159.57184.85217.78
Shareholders' Equity
352.59352.46229.02159.57184.85217.78
Total Liabilities & Equity
406.69418.43271.56228.34256.07238.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.924.154.776.845.085.04
Net Cash (Debt)
356.87386.78241.95194.56224.52214.77
Net Cash Growth
10.20%59.86%24.36%-13.34%4.54%-24.95%
Net Cash Per Share
5.506.534.484.425.775.85
Filing Date Shares Outstanding
65.4159.1554.0846.344.1537.36
Total Common Shares Outstanding
64.8158.9254.0345.9239.4436.9
Working Capital
305.44247.83192.7184.52212.68212.08
Book Value Per Share
5.445.984.243.474.695.90
Tangible Book Value
352.59352.46229.02159.57184.85217.78
Tangible Book Value Per Share
5.445.984.243.474.695.90
Machinery
-10.4610.3110.148.574.93
Construction In Progress
-0.620.120.070.451.61
Leasehold Improvements
-2.212.332.291.870.26
SEC Filings: 10-K · 10-Q